Intraocular lenses and experimental bacterial endophthalmitis

American Journal of Ophthalmology
G HopenJ Lipkowitz

Abstract

To determine if an intraocular lens renders bacterial endophthalmitis more resistant to therapy, an animal model was developed. Nine rabbits underwent bilateral extracapsular lens extraction with placement of a Simcoe posterior chamber IOL in one eye. Approximately 170 organisms of Staphylococcus aureus were inoculated into both eyes. The eyes of seen animals were treated with intravitreal and subconjunctival gentamicin after 24 and 48 hours. Vitreous cultures remained sterile in all treated eyes for one week after antibiotic therapy. Two animals that did not receive antibiotics showed persistent infection. There was no difference between aphakic and pseudophakic eyes in terms of clinical response or onset of negative cultures.

References

Aug 1, 1978·American Journal of Ophthalmology·D M EichenbaumD S Light
Nov 1, 1979·American Journal of Ophthalmology·D N GerdingM D Clark
Jul 1, 1979·Archives of Ophthalmology·J B Michelson, R A Nozik
May 1, 1977·American Journal of Surgery·G RodeheaverR Edlich
Jun 1, 1979·Disease-a-month : DM·A S Bayer, L B Guze
Nov 1, 1979·Progress in Cardiovascular Diseases·C Watanakunakorn
May 18, 1979·JAMA : the Journal of the American Medical Association·F E Kloster
Oct 1, 1979·Journal - American Intra-Ocular Implant Society·A G Parelman
May 1, 1977·Archives of Surgery·D B Kettlekamp
Jan 1, 1975·Archives of Ophthalmology·R O GrahamG Fishman
Aug 1, 1974·Archives of Ophthalmology·R O Graham, G A Peyman
Dec 1, 1972·Archives of Ophthalmology·D N Tucker, R K Forster
Feb 1, 1982·American Journal of Ophthalmology·G W Zaidman, B J Mondino
Dec 1, 1980·Acta Médica Portuguesa·J R Pluth
May 24, 1980·British Medical Journal
Sep 1, 1980·The British Journal of Ophthalmology·D J SchanzlinS I Brown
Oct 1, 1980·Acta Orthopaedica Scandinavica·G Blomgren, U Lindgren

❮ Previous
Next ❯

Citations

May 1, 1984·American Journal of Ophthalmology·C M Gilbert, M A Novak
Dec 14, 1999·Survey of Ophthalmology·E J LinebargerR L Lindstrom
Apr 1, 1986·Ophthalmology·W T DriebeW W Culbertson
Sep 1, 1987·Journal of Cataract and Refractive Surgery·K L PiestF W Price
Jul 1, 1985·Survey of Ophthalmology·R ChampionW R Green
Jul 1, 1984·Survey of Ophthalmology·D J AppleR J Olson
Aug 15, 1984·American Journal of Ophthalmology·D F MarcusP T Nelsen
Mar 15, 2006·Current Eye Research·Clare C McCormickRichard J O'Callaghan
Oct 1, 1989·Acta Ophthalmologica·S KoulA Philipson
Apr 21, 1998·Survey of Ophthalmology·A N CarlsonP C Tso

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.